论文部分内容阅读
目的监测并分析甲型H1N1流感疫苗的安全性和疑似预防接种异常反应(AEFI)发生特征,评价AEFI监测系统运转情况。方法对内蒙古2009-2010年甲型H1N1流感疫苗接种后发生并报告的预防接种异常反应进行调查分析。结果全自治区报告疑似预防接种异常反应88例,一般反应67例,异常反应17例,偶合症1例,心因性反应2例,待定1例。24 h内监测到AEFI病例62例。异常反应中,过敏性皮疹占52.94%。结论甲型H1N1流感疫苗安全性较好。
Objective To monitor and analyze the safety of influenza A (H1N1) vaccine and the characteristics of suspected antivirus vaccination (AEFI) and evaluate the operation of AEFI surveillance system. Methods Investigation and analysis of the abnormalities in vaccination occurred after the vaccination of Influenza A (H1N1) in Inner Mongolia between 2009 and 2010 were conducted. Results The autonomous region reported 88 cases of suspected abnormal immunization, 67 cases of general reaction, 17 cases of abnormal reaction, 1 case of coupling syndrome, 2 cases of cardiogenic reaction and 1 case of pending treatment. AEFI cases were detected in 62 cases within 24 hours. Abnormal reaction, allergic rash accounted for 52.94%. Conclusion Influenza A H1N1 influenza vaccine is safe.